Trial Profile
Treatment of Severe Fibromyalgia Syndrome Associated to Functional Failure of Somatotropic Axis With Recombinant Growth Hormone. A Multicenter, Randomized, Double Blind, Placebo Controlled Study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- Sponsors EMD Serono
- 01 Jul 2012 Primary endpoint 'Tender-point-count' has been met.
- 12 Dec 2011 Trial trial location (Spain) identified as reported by ClinicalTrials.gov.
- 12 Dec 2011 Additional trial affiliate (Merck KGaA), location and actual end date (Jul 2010) added as reported by ClinicalTrials.gov.